Precision Medicine - A Basis for Partnership Between Health Systems and Industry

Properly understood by both, precision medicine (PM) represents a shared agenda for the future between health systems and industry. Using advanced diagnostics to target therapies and to track their effectiveness in the real world using precision, personalised digital tools can enable a sustainable partnership based on value delivered. We already see this emerging in cancer and inherited disease. As PM tools, including AI, begin to be applied to the chronic diseases that represent the greatest burden on both the patient population and system economics, they will play an increasing part in securing healthy longevity and health system sustainability.